Post by Algaurizin

The AI Integration Tracker (ASCO 2026 Special Report) How are AI tools actually performing in oncology? Our new ASCO 2026 special report ranks the five leading AI‑integrated oncology platforms by evidence strength, with trial counts, RCTs, abstracts, and a clear Algaurizin assessment for each. Key takeaways: - 5 platforms tracked | 2 RCT‑level studies | 142K participants (largest trial) | 80+ abstracts - Clear evidence legend (RCT, Prospective, Retrospective, Platform demo)  - Feature analysis: top platform, ranked #1, RCT evidence, Strength: High Read the full visual report: https://lnkd.in/diEdMMPN #AIinHealthcare #Oncology #ASCO2026 #ClinicalEvidence #MedTech #Algaurizin